PYC Therapeutics Management
Management criteria checks 4/4
We currently do not have sufficient information about the CEO.
Key information
Rohan Hockings
Chief executive officer
AU$433.2k
Total compensation
| CEO salary percentage | 91.2% |
| CEO tenure | 4.3yrs |
| CEO ownership | n/a |
| Management average tenure | 4.3yrs |
| Board average tenure | 3.7yrs |
Recent management updates
No updates
Recent updates
No updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | AU$433k | AU$395k | -AU$38m |
| Mar 31 2024 | n/a | n/a | -AU$30m |
| Dec 31 2023 | n/a | n/a | -AU$22m |
| Sep 30 2023 | n/a | n/a | -AU$22m |
| Jun 30 2023 | AU$438k | AU$395k | -AU$23m |
| Mar 31 2023 | n/a | n/a | -AU$23m |
| Dec 31 2022 | n/a | n/a | -AU$24m |
| Sep 30 2022 | n/a | n/a | -AU$19m |
| Jun 30 2022 | AU$418k | AU$395k | -AU$14m |
| Mar 31 2022 | n/a | n/a | -AU$15m |
| Dec 31 2021 | n/a | n/a | -AU$17m |
| Sep 30 2021 | n/a | n/a | -AU$17m |
| Jun 30 2021 | n/a | n/a | -AU$18m |
| Mar 31 2021 | n/a | n/a | -AU$15m |
| Dec 31 2020 | n/a | n/a | -AU$12m |
| Sep 30 2020 | n/a | n/a | -AU$9m |
| Jun 30 2020 | AU$471k | AU$395k | -AU$7m |
| Mar 31 2020 | n/a | n/a | -AU$6m |
| Dec 31 2019 | n/a | n/a | -AU$5m |
| Sep 30 2019 | n/a | n/a | -AU$5m |
| Jun 30 2019 | AU$482k | AU$395k | -AU$4m |
| Mar 31 2019 | n/a | n/a | -AU$4m |
| Dec 31 2018 | n/a | n/a | -AU$5m |
| Sep 30 2018 | n/a | n/a | -AU$6m |
| Jun 30 2018 | AU$377k | AU$84k | -AU$7m |
Compensation vs Market: Rohan's total compensation ($USD282.53K) is below average for companies of similar size in the Australian market ($USD921.54K).
Compensation vs Earnings: Rohan's compensation has been consistent with company performance over the past year.
CEO
Rohan Hockings (41 yo)
4.3yrs
Tenure
AU$433,210
Compensation
Dr. Rohan Hockings, MBBS (Hons.), J.D., G.D.L.P, has been Chief Executive Officer at PYC Therapeutics Limited since August 2020. He served as Chief Strategy Officer at PYC Therapeutics Limited until August...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Director | 4.3yrs | AU$433.21k | no data | |
| CFO & Company Secretary | 2.6yrs | no data | no data | |
| Company Secretary | 7.3yrs | AU$165.90k | no data |
4.3yrs
Average Tenure
Experienced Management: PYCDA's management team is considered experienced (4.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Director | 6yrs | AU$433.21k | no data | |
| Independent Non-Executive Director | 3.7yrs | AU$86.67k | no data | |
| Member of Ophthalmology Clinical Advisory Board | 3.3yrs | no data | no data | |
| Independent Director | 3.7yrs | AU$86.67k | no data | |
| Non-Executive Chair of the Board | 6.6yrs | AU$70.00k | 34.02% A$ 284.1m | |
| Member of Scientific Advisory Board & Member of Ophthalmology Clinical Advisory Board | 5.2yrs | no data | no data | |
| Member of Ophthalmology Clinical Advisory Board | 3.3yrs | no data | no data | |
| Member of Ophthalmology Clinical Advisory Board | 3.3yrs | no data | no data |
3.7yrs
Average Tenure
65yo
Average Age
Experienced Board: PYCDA's board of directors are considered experienced (3.7 years average tenure).